Concanavalin A aggregation and toxicity on cell cultures.

Area of Science:

• Biochemistry
• Cell Biology
• Neuroscience

Background:

• Protein aggregation is implicated in neurodegenerative diseases.
• Amyloid structures and aggregation mechanisms are linked to cytotoxicity.
• Concanavalin A (Con A) serves as a model for studying aggregation-related toxicity.

Purpose of the Study:

• To investigate the relationship between Concanavalin A (Con A) aggregation and cell toxicity.
• To characterize the morphology and conformational changes during Con A aggregation.
• To determine the cytotoxic effects of different Con A aggregate species on neuroblastoma cells.

Main Methods:

• Con A aggregation monitored by light scattering, Thioflavin T emission, and FTIR.
• Aggregate morphology analyzed using Atomic Force Microscopy and Confocal Microscopy.
• Cytotoxicity assessed via MTS assay on LAN5 neuroblastoma cells, with apoptosis analysis.

Main Results:

• Con A aggregation involves simultaneous conformational changes and aggregate formation.
• Native Con A and oligomers exhibit toxicity, while mature fibrils show negligible effects.
• Both native and oligomeric forms activate apoptosis via the extrinsic pathway (caspase 8).

Conclusions:

• Cytotoxicity arises from specific membrane interactions with destabilized protein conformations during early aggregation.
• Mature amyloid fibrils are non-toxic because reactive conformations are sequestered within the fibrillar structure.
• This suggests that the stage of protein aggregation, not just the presence of aggregates, dictates cellular toxicity.